Capricorn Fund Managers Dumps $18.4 Million Worth of Waystar Stock in Q1

2 hours ago 1

Josh Kohn-Lindquist, The Motley Fool

Fri, April 24, 2026 astatine 12:07 PM CDT 4 min read

According to an SEC filing dated April 24, 2026, Capricorn Fund Managers reduced its involvement successful Waystar (NASDAQ:WAY) by 692,554 shares during the archetypal 4th of 2026. The estimated transaction worth was $18.38 million, calculated utilizing the mean unadjusted closing terms for the quarter. The position’s quarter-end worth fell by $23.08 million, a fig driven by some the merchantability and marketplace terms changes.

Following the sale, Waystar represents 0.17% of Capricorn’s $641.43 cardinal successful U.S. equity holdings.

  • Top holdings aft the filing:

    • Carvana: $29.87 cardinal (4.7% of AUM)

    • Bank of America: $26.18 cardinal (4.1% of AUM)

    • Zymeworks: $25.22 cardinal (3.9% of AUM)

    • Axogen: $22.78 cardinal (3.6% of AUM)

    • KKR & Co.: $19.61 cardinal (3.1% of AUM)

As of April 23, 2026, Waystar shares were trading astatine $24.85, down 32.5% implicit the past twelvemonth and underperforming the S&P 500 by 65 percent points.

Metric

Value

Price (as of marketplace adjacent April 23, 2026)

$24.85

Market capitalization

$4.76 billion

Revenue (TTM)

$1.10 billion

Net income (TTM)

$112.09 million

  • Waystar provides a cloud-based bundle level focused connected healthcare payments, including fiscal clearance, diligent fiscal care, claims and outgo management, denial prevention and recovery, gross capture, and analytics.

  • Its superior customers are healthcare providers and organizations seeking to streamline and optimize outgo workflows and fiscal operations.

  • Founded successful 2017 and based successful Lehi, Utah, Waystar operates successful the exertion assemblage with astir 1,500 employees.

Waystar operates astatine scale, with a marketplace capitalization of $4.76 cardinal and trailing-12-month gross of $1.10 billion. The company's level addresses captious symptom points successful healthcare outgo processing, offering integrated solutions that heighten ratio and trim administrative burdens for providers. Its cloud-based, SaaS concern exemplary positions it to payment from ongoing integer translation successful healthcare fiscal operations.

Waystar IPO’d successful June 2024 and saw its stock terms treble wrong a year. Since then, it has astir returned to wherever it started, and it looks similar Capricorn tried to bargain the dip on the way. However, aft buying shares of Waystar successful Q3 and Q4 past twelvemonth astatine astir $35 per share, the steadfast sold the bulk of its WAY involvement successful Q1 this year, portion the banal traded adjacent $24.

It’s intolerable to accidental wherefore Capricorn made this move, but it is worthy noting that they typically bash not clasp their shares for precise long, truthful existent oregon prospective WAY shareholders shouldn’t panic implicit this news. In fact, I’d reason that Waystar is simply a beauteous absorbing banal -- particularly pursuing the diminution that galore caller IPOs spot aft their archetypal “pop.”

Read Entire Article